1. [Is preoperative axillary radio-cytology justified after ACOSOG Z001?]
- Author
-
Defer A, Tessier V, Haudebourg J, Dejode M, Gosset M, Barranger E, and Delpech Y
- Subjects
- Adult, Aged, Aged, 80 and over, Axilla, Biopsy, Fine-Needle statistics & numerical data, Breast Neoplasms diagnostic imaging, Breast Neoplasms surgery, Clinical Trials as Topic, Disease-Free Survival, Female, Humans, Lymphatic Metastasis pathology, Middle Aged, Preoperative Care, Radiography, Retrospective Studies, Sentinel Lymph Node Biopsy statistics & numerical data, Breast Neoplasms pathology, Lymph Node Excision methods, Sentinel Lymph Node pathology
- Abstract
Introduction: Invasive breast cancer without clinical adenopathy (cN0) is currently explored by the sentinel node (GS) technique, except in the case of positive preoperative radio-cytological screening, where axillary curage (CA) remains systematic from the outset. Since the publication of the ACOSOG-Z0011 trial, abstention from CA is possible in patients presenting less than three metastatic GS. As a result, the value of axillary radio-cytological screening is being questioned as it could potentially lead to axillary surgical over-treatment. The objective of this study was to study clinically N0 patients with positive axillary cytology and to compare it to a group of patients with positive GS., Method: One hundred and forty-seven patients with cN0 pN+ breast cancer treated between 2014 and 2016 were selected retrospectively. Two groups were constituted according to the initial radio-cytological evaluation. A CA was systematically performed., Results: Thirty-one patients with positive axillary cytology (n=31 vs. n=116) had more metastatic lymph nodes (P=0.01) in the AC, larger (P<0.001), less differentiated (P<0.001) tumours, and shorter recurrence-free survival (P=0.0114). It also appeared that 38.7 % of patients with a positive cytology had at most two metastatic nodes and could, according to the results of ACOSOG, benefit from therapeutic de-escalation., Conclusion: X-ray cytological screening remains essential in order to select a subgroup of patients with a high lymph node tumour load. Additional studies are necessary in order to be able to offer therapeutic de-escalation to 1/3 of these patients without the risk of under-treatment for the remaining 2/3., (Copyright © 2021 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF